Dr. William Robert Harmon Jr., OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 Macomb, Mt Clemens, MI 48043 Phone: 586-468-7612 Fax: 586-468-9701 |
Pearle Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 37561 S Gratiot Ave, Mt Clemens, MI 48036 Phone: 586-469-1200 Fax: 586-469-3540 |
News Archive
BioMarin Pharmaceutical Inc. announced today preliminary results from ADAPT (A Diversified Approach for PKU Treatment) in an abstract (Abstract #91, Mental Health Screening in Phenylketoniuria Clinic) presented by Barbara Burton, MD at the 2011 annual American College of Medical Genetics conference in Vancouver, Canada.
The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease. Recent studies have shown that a main source of this cardiovascular risk is CKD patients' high levels of blood phosphate.
Hospitals around the world are looking for new and innovative ways to battle deadly pathogens and kill multidrug resistant organisms that can cause hospital-acquired infections, or HAI.
Regeneron Pharmaceuticals, Inc. today announced that in the Phase 3 VIVID-DME trial of EYLEA® (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation.
› Verified 8 days ago